UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 16, 2017
SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
|
001-34465 |
|
20-1764048 |
|
(State or other jurisdiction of |
|
(Commission File |
|
(I.R.S. Employer |
4714 Gettysburg Road, P.O. Box 2034
Mechanicsburg, PA 17055
(Address of principal executive offices) (Zip Code)
(717) 972-1100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 16, 2017, the Boards of Directors (the “Boards”) of Select Medical Holdings Corporation (“Holdings”) and Select Medical Corporation (“Select”) appointed Dr. Harold L. Paz as a director of each of Holdings and Select, effective on March 1, 2017. Dr. Paz will serve on the Quality of Care and Patient Safety Committee of each of Holdings and Select. His term will expire at the 2017 Annual Meeting of Stockholders of Holdings, at which time he will stand for election along with the other director nominees standing for election at that meeting. Dr. Paz will be eligible for compensation as a non-employee director of Holdings as described under the heading “Director Compensation” in the Proxy Statement for the 2016 Annual Meeting of Stockholders of Holdings filed with the Securities and Exchange Commission on March 3, 2016.
Item 7.01 Regulation FD Disclosure.
Attached as Exhibit 99.1 and furnished for purposes of Regulation FD is a press release issued by Holdings on February 21, 2017, announcing the appointment of Dr. Paz to the Board of Directors of Holdings.
The information in this Item 7.01 in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit Number |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release, dated February 21, 2017, announcing the appointment of Dr. Harold L. Paz to the Board of Directors of Select Medical Holdings Corporation. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.
|
|
SELECT MEDICAL HOLDINGS CORPORATION | |
|
|
SELECT MEDICAL CORPORATION | |
|
|
|
|
|
|
|
|
|
Date: February 21, 2017 |
By: |
/s/ Michael E. Tarvin |
|
|
|
Michael E. Tarvin |
|
|
|
Executive Vice President, General Counsel and Secretary |